Patent US3962243A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3962243A Expired / Lapsed US ⏱️ 0.0 years remaining

Mepyramine theophylline acetate

Assignee: LABORATORIES MADE SA
•
Filing: 1974-10-16
•
Granted: 1976-06-08
•
Expires: 1994-10-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The 7-theophylline acetic acid salt of mepyramine possesses bronchial spasmolytic, antiarrhythmic, cerebral oxidation inhibitor and platelet aggregation inhibitor properties. It is prepared by slowly adding a solution of mepyramine to a suspension of 7-theophylline acetic acid in the same solvent to effect the salt-forming reaction. It can be incorporated in various pharmaceutical unit dosage forms.

Inventors

  • 👤 Cristobal Martinez Roldan
  • 👤 Miguel Fernandez Brana
  • 👤 Jose Maria Castellano Berlanga

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 19:39
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/72; C07D213/74; C07D473/00; C07D473/02; C07D473/04; C07D473/06; C07D473/08

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 3 words
2-[(2-dimethylaminoethyl) (p-methoxybenzyl)amino]pyridine 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurin-7-acetate.
Claim 2
Dependent Claim 3 words
2-[(2-dimethylaminoethyl) (p-methoxybenzyl)amino]pyridine 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxopurin-7-acetate.

References Cited (Backward Citations)

US2534235A Cited
US2942000A Cited
US3098854A Cited
US3190920A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-06-08 1979-12-08 1980-06-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-06-08 1983-12-08 1984-06-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-06-08 1987-12-08 1988-06-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag